Invesco
TNGX icon

Invesco’s Tango Therapeutics TNGX Stock Holding History

Invesco’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Sell
462,721
-117,732
-20% -$2.91M ﹤0.01% 1696
2026
Q1 		$12.1M Buy
580,453
+402,843
+227% +$5.61M ﹤0.01% 1729
2025
Q4 		$1.57M Sell
177,610
-854,307
-83% -$7.36M ﹤0.01% 2708
2025
Q3 		$8.67M Buy
1,031,917
+936,624
+983% +$6.34M ﹤0.01% 1910
2025
Q2 		$488K Buy
95,293
+24,776
+35% +$61.3K ﹤0.01% 3161
2025
Q1 		$96.6K Buy
70,517
+40,983
+139% +$101K ﹤0.01% 3626
2024
Q4 		$91.3K Buy
29,534
+584
+2% +$2.71K ﹤0.01% 3636
2024
Q3 		$223K Buy
28,950
+517
+2% +$4.93K ﹤0.01% 3493
2024
Q2 		$244K Buy
28,433
+379
+1% +$2.93K ﹤0.01% 3558
2024
Q1 		$223K Sell
28,054
-439,199
-94% -$4.71M ﹤0.01% 3607
2023
Q4 		$4.63M Sell
467,253
-307,485
-40% -$2.67M ﹤0.01% 2281
2023
Q3 		$8.72M Buy
774,738
+751,593
+3,247% +$4.58M ﹤0.01% 1857
2023
Q2 		$76.8K Sell
23,145
-860
-4% -$3.09K ﹤0.01% 3767
2023
Q1 		$94.8K Sell
24,005
-189,278
-89% -$1.1M ﹤0.01% 3709
2022
Q4 		$1.55M Buy
213,283
+189,952
+814% +$1.34M ﹤0.01% 2739
2022
Q3 		$85K Sell
23,331
-36
-0.2% -$154 ﹤0.01% 3862
2022
Q2 		$105K Buy
+23,367
New +$141K ﹤0.01% 3878

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Invesco's TNGX Position: Q2 2026 in Review

Invesco reduced its Tango Therapeutics (TNGX) stake by 20% in Q2 2026, selling an estimated $2.91M and leaving 462,721 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Invesco first reported a position in TNGX in Q2 2022 and has held it in 17 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Invesco held 462,721 shares of Tango Therapeutics worth $14.5M as of Q2 2026.
  • Invesco sold 117,732 Tango Therapeutics shares in Q2 2026, an estimated $2.91M.
  • Tango Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1696 holding.
  • Invesco first reported a position in Tango Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.